A correlation of endocrine and anticancer effects of some antagonists of GHRH. (Q39679789)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

title

A correlation of endocrine and anticancer effects of some antagonists of GHRH (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

Ferenc Rick

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

3

Florian Hohla

1 reference

7 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

Luca Szalontay

6

object named as

Luca Szalontay

1 reference

7 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

author name string

Magdolna Kovács

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

Eva Pozsgai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

József L Varga

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

Márta Zarándi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

publication date

13 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Peptides

1 reference

13 September 2017

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1839-1846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.

7 February 2020

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Lessons learned in the development of targeted therapy for malignant gliomas.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Evidence for a link between IGF-I and cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Inhibition of GH release of rats by new potent antagonists of growth hormone-releasing hormone (GH-RH).

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

The rat growth hormone-releasing hormone receptor gene: structure, regulation, and generation of receptor isoforms with different signaling properties

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Physiological studies with somatocrinin, a growth hormone-releasing factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Inhibitory effects of antagonistic analogs of GHRH on GH3 pituitary cells overexpressing the human GHRH receptor.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Molecular basis of the little mouse phenotype and implications for cell type-specific growth

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

The effect of GHRH antagonists on human glioblastomas and their mechanism of action

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Endocrine and antineoplastic actions of growth hormone-releasing hormone antagonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

The insulin-like growth factor system and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.PEPTIDES.2010.07.006

Identifiers

DOI

10.1016/J.PEPTIDES.2010.07.006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20633588 AND SRC:MED&resulttype=core&format=json

release_6hvpzgik6jcvpomvbqqbzqcdta

7 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6hvpzgik6jcvpomvbqqbzqcdta

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference